{"id":9216,"date":"2025-07-22T07:10:15","date_gmt":"2025-07-22T12:10:15","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=9216"},"modified":"2025-07-23T18:30:25","modified_gmt":"2025-07-23T23:30:25","slug":"nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u72ec\u81ea\u306e\u5e83\u5e2f\u57df\u304b\u3064\u9ad8\u901f\u306a\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u6280\u8853\u306e\u4f5c\u7528\u6a5f\u5e8f\u306e\u8a73\u7d30\u3092\u767a\u8868"},"content":{"rendered":"
\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u65b0\u305f\u306a\u7814\u7a76\u8ad6\u6587\u306f\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u5408\u6210\u30aa\u30d7\u30b7\u30f3\u306e\u72ec\u81ea\u306e\u69cb\u9020\u3068\u6a5f\u80fd\u306b\u7126\u70b9\u3092\u5f53\u3066\u3001\u8996\u529b\u56de\u5fa9\u306b\u304a\u3051\u308b\u305d\u306e\u53ef\u80fd\u6027\u3092\u88cf\u4ed8\u3051\u3066\u3044\u308b\u3002<\/h3>\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a02025\u5e747\u670822\u65e5<\/span><\/span>\u00a0\u2014\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>, \u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308b\u8996\u529b\u55aa\u5931\u306b\u82e6\u3057\u3080\u60a3\u8005\u306e\u305f\u3081\u306e\u65b0\u898f\u907a\u4f1d\u5b50\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3068\u5546\u696d\u5316\u306b\u53d6\u308a\u7d44\u3080\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b[\u4f01\u696d\u540d]\u306f\u672c\u65e5\u3001\u8ad6\u6587\u306e\u767a\u8868\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u00a0\u201c<\/b>\u300c\u795e\u7d4c\u8abf\u7bc0\u306e\u305f\u3081\u306e\u5e83\u5e2f\u57df\u304b\u3064\u9ad8\u901f\u306a\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u306e\u30c8\u30dd\u30ed\u30b8\u30fc\u3068\u30e1\u30ab\u30cb\u30ba\u30e0\u300d\u201d<\/b><\/a>\u00a0\u3067\u00a0\u30a2\u30c9\u30d0\u30f3\u30b9\u30c8\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001,\u00a0<\/i>\u30ef\u30a4\u30ea\u30fc\u793e\u306e\u6a29\u5a01\u3042\u308b\u67fb\u8aad\u4ed8\u304d\u5b66\u8853\u8a8c\u00a0\u9ad8\u5ea6\u306a<\/i>\u00a0\u5f71\u97ff\u529b\u306e\u5927\u304d\u3044\u751f\u7269\u533b\u5b66\u7814\u7a76\u3092\u7d39\u4ecb\u3059\u308b\u3053\u3068\u3067\u77e5\u3089\u308c\u308b\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3002\u672c\u8ad6\u6587\u3067\u306f\u3001\u4e88\u6e2c\u30bf\u30f3\u30d1\u30af\u8cea\u30e2\u30c7\u30ea\u30f3\u30b0\u3001\u5206\u5b50\u30a2\u30c3\u30bb\u30a4\u3001\u96fb\u6c17\u751f\u7406\u5b66\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u72ec\u81ea\u306e\u69cb\u9020\u3068\u6a5f\u80fd\u306a\u3069\u3001Nanoscope\u72ec\u81ea\u306e\u6cbb\u7642\u6cd5\u3067\u3042\u308bMCO\u306e\u751f\u7269\u7269\u7406\u5b66\u7684\u7279\u6027\u3092\u8a73\u7d30\u306b\u89e3\u8aac\u3057\u3066\u3044\u308b\u3002.<\/p>\n

\u672c\u8ad6\u6587\u306f\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u4e3b\u8981\u958b\u767a\u5019\u88dc\u6cbb\u7642\u85ac\u3067\u3042\u308bMCO-010\u3067\u6cbb\u7642\u3092\u53d7\u3051\u305f\u60a3\u8005\u306b\u898b\u3089\u308c\u308b\u52b9\u679c\u3092\u88cf\u4ed8\u3051\u308b\u3001\u540c\u793e\u306e\u753b\u671f\u7684\u306a\u7814\u7a76\u6210\u679c\u3092\u5f37\u8abf\u3057\u3066\u3044\u308b\u3002\u3053\u306e\u7814\u7a76\u7d50\u679c\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308b\u69d8\u3005\u306a\u8996\u529b\u55aa\u5931\u306b\u82e6\u3057\u3080\u4eba\u3005\u3092\u652f\u63f4\u3059\u308b\u305f\u3081\u306b\u3001\u3053\u306e\u6280\u8853\u3092\u3055\u3089\u306b\u767a\u5c55\u3055\u305b\u308b\u305f\u3081\u306e\u57fa\u790e\u3068\u306a\u308b\u3082\u306e\u3067\u3042\u308b\u3002\u96fb\u6c17\u8a18\u9332\u3092\u7528\u3044\u305f\u6a5f\u80fd\u7814\u7a76\u3067\u306f\u3001MCO\u306f\u5468\u56f2\u5149\u306b\u3088\u3063\u3066\u6d3b\u6027\u5316\u3055\u308c\u3001\u9ad8\u3044\u5149\u611f\u5ea6\u3067\u9ad8\u901f\u306a\u30aa\u30f3\u30aa\u30d5\u52d5\u614b\u3092\u793a\u3057\u3001\u53ef\u8996\u5149\u30b9\u30da\u30af\u30c8\u30eb\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u5e83\u3044\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u30ec\u30f3\u30b8\u3092\u7dad\u6301\u3059\u308b\u3053\u3068\u304c\u5b9f\u8a3c\u3055\u308c\u3066\u304a\u308a\u3001MCO\u767a\u73fe\u7d30\u80de\u306e\u5f37\u529b\u304b\u3064\u6700\u9ad8\u30af\u30e9\u30b9\u306e\u5149\u6d3b\u6027\u5316\u3092\u53ef\u80fd\u306b\u3059\u308b\u3002.<\/p>\n

\u201c\u300c\u5f53\u793e\u306e\u74b0\u5883\u5149\u6d3b\u6027\u5316\u578bMCO\u306e\u975e\u5e38\u306b\u52b9\u7387\u7684\u306a\u4f5c\u7528\u6a5f\u5e8f\u306f\u3001\u5e83\u5e2f\u57df\u306e\u5149\u611f\u5ea6\u3068\u9ad8\u901f\u30c1\u30e3\u30cd\u30eb\u52d5\u614b\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u72ec\u81ea\u306e\u69cb\u9020\u306b\u7531\u6765\u3057\u307e\u3059\u300d\u3068\u8ff0\u3079\u305f\u3002\u00a0\u535a\u58eb\u3002\u00a0\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>, \u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/a>\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306b\u6240\u5c5e\u3057\u3001\u8ad6\u6587\u306e\u7b46\u982d\u8457\u8005\u3067\u3042\u308b\u3002\u300c\u3053\u306e\u7814\u7a76\u3068\u8907\u6570\u306e\u81e8\u5e8a\u7814\u7a76\u306b\u57fa\u3065\u304d\u3001\u30ed\u30fc\u30ea\u30f3\u30b0\u6295\u7a3f\u306f\u00a0MCO-010\u306e\u751f\u7269\u88fd\u5264\u627f\u8a8d\u7533\u8acb\u3092FDA\u306b\u6700\u8fd1\u958b\u59cb\u3057\u305f\u3002<\/a>, \u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u6cbb\u7642\u3059\u308b\u521d\u306e\u907a\u4f1d\u5b50\u975e\u4f9d\u5b58\u578b\u6cbb\u7642\u6cd5\u3068\u306a\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u308b\u3002\u300d\u201d<\/p>\n

\u878d\u5408\u578bMCO\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u72ec\u7279\u306a\u30c8\u30dd\u30ed\u30b8\u30fc\u7279\u6027\u3068\u6a5f\u80fd\u7684\u6d3b\u6027\u5316\u7279\u6027\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u3092\u76ee\u6307\u3059\u795e\u7d4c\u8abf\u7bc0\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u3001\u3053\u306e\u30aa\u30d7\u30b7\u30f3\u306e\u8a66\u9a13\u7ba1\u5185\u304a\u3088\u3073\u751f\u4f53\u5185\u3067\u306e\u6709\u52b9\u6027\u3092\u7d50\u3073\u3064\u3051\u308b\u65b0\u305f\u306a\u767a\u898b\u3067\u3042\u308b\u3002.<\/p>\n

\u535a\u58eb\u3002\u00a0\u30a2\u30a4\u30aa\u30cd\u30fb\u30d5\u30a1\u30a4\u30f3<\/span>, \u3001\u5fc3\u7406\u5b66\u90e8\u6559\u6388\u00a0\u30ef\u30b7\u30f3\u30c8\u30f3\u5927\u5b66<\/span><\/a>,\u00a0\u30b7\u30a2\u30c8\u30eb<\/span>, \u300c\u3053\u306e\u8ad6\u6587\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u958b\u767a\u4e2d\u306e\u4ed6\u306e\u30aa\u30d7\u30b7\u30f3\u3068MCO\u306e\u6027\u80fd\u3092\u5305\u62ec\u7684\u306b\u6bd4\u8f03\u3057\u305f\u3082\u306e\u3067\u3059\u3002\u305d\u306e\u305f\u3081\u3001MCO\u3084\u4ed6\u306e\u30aa\u30d7\u30b7\u30f3\u3067\u6cbb\u7642\u3092\u53d7\u3051\u305f\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u3092\u4e88\u6e2c\u3059\u308b\u305f\u3081\u306e\u8a08\u7b97\u30e2\u30c7\u30eb\u69cb\u7bc9\u3092\u652f\u63f4\u3059\u308b\u4e0a\u3067\u3001\u91cd\u8981\u306a\u77e5\u898b\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u300d\u3068\u30b3\u30e1\u30f3\u30c8\u3057\u305f\u3002\u201c<\/p>\n

\u63b2\u8f09\u3055\u308c\u305f\u8ad6\u6587\u306f\u3053\u3061\u3089\u3092\u30af\u30ea\u30c3\u30af\u3057\u3066\u3054\u89a7\u304f\u3060\u3055\u3044\u3002.<\/a><\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u3067\u5931\u660e\u3057\u305f\u6570\u767e\u4e07\u4eba\u306e\u60a3\u8005\u306b\u5bfe\u3057\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u3002\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3092\u5bfe\u8c61\u3068\u3057\u305f\u591a\u65bd\u8a2d\u5171\u540c\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u76f2\u691c\u30d7\u30e9\u30bb\u30dc\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u3067\u3042\u308bRESTORE\u7b2c2b\u76f8\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u7d50\u679c\u3092\u53d7\u3051\u3066\u3001\u540c\u793e\u306f\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u306b\u7740\u624b\u3057\u305f\u3002 (NCT04945772)<\/a>, \u540c\u793e\u306f\u3001\u00a0RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>. \u627f\u8a8d\u3055\u308c\u308c\u3070\u3001MCO-010\u306f\u907a\u4f1d\u5b50\u691c\u67fb\u3092\u5fc5\u8981\u3068\u305b\u305a\u3001\u5916\u6765\u30671\u56de\u785d\u5b50\u4f53\u5185\u6ce8\u5c04\u3068\u3057\u3066\u6295\u4e0e\u3055\u308c\u308bRP\u60a3\u8005\u306e\u6a19\u6e96\u6cbb\u7642\u3068\u306a\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u308b\u3002\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\u306b\u5bfe\u3059\u308bMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8\u81e8\u5e8a\u8a66\u9a13\u3067\u3042\u308bSTARLIGHT\u8a66\u9a13\u306b\u304a\u3044\u3066\u6709\u671b\u306a\u7d50\u679c\u3092\u793a\u3057\u3066\u3044\u308b\u3002 (NCT05417126)<\/a> \u305d\u3057\u3066\u958b\u59cb\u3059\u308b\u8a08\u753b\u00a0\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02025\u5e74\u306b\u767a\u58f2\u4e88\u5b9a\u306eMCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3068\u30b9\u30bf\u30d5\u30a3\u30f3\u30fb\u30c7\u30a3\u30d5\u30a3\u30b7\u30eb\uff08SD\uff09\u306e\u4e21\u65b9\u306b\u3064\u3044\u3066\u3001FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001IND\u7533\u8acb\u306b\u5411\u3051\u305f\u7814\u7a76\u6bb5\u968e\u306b\u3042\u308b\u30ec\u30fc\u30d0\u30fc\u5148\u5929\u6027\u9ed2\u5185\u969c\uff08LCA\uff09\u306e\u307b\u304b\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\uff08GA\uff09\u306b\u5bfe\u3059\u308bIND\u7533\u8acb\u6e96\u5099\u6bb5\u968e\u306e\u85ac\u5264\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9
(817) 857-1186
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

New research paper highlights the unique structure and function of Nanoscope\u2019s synthetic opsin, supporting its potential in vision restoration DALLAS,\u00a0July 22, 2025\u00a0\u2014\u00a0Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene therapies for patients suffering vision loss from retinal degenerative diseases, today announced the publication of a paper\u00a0\u201cTopology and Mechanism of Broadband and Fast Multi-Characteristic Opsin (MCO) for Neuromodulation,\u201d\u00a0in\u00a0Advanced Therapeutics,\u00a0a peer-reviewed journal in Wiley\u2019s prestigious\u00a0Advanced\u00a0portfolio, known for showcasing high impact biomedical research. The paper details the biophysical characteristics of Nanoscope\u2019s proprietary therapeutic approach, MCO, including its unique structure and function, which utilizes a combination of predictive protein modeling, molecular assays, and electrophysiology. The paper highlights Nanoscope\u2019s groundbreaking […]<\/p>\n","protected":false},"author":6,"featured_media":9217,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-9216","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-22T12:10:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-23T23:30:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology\",\"datePublished\":\"2025-07-22T12:10:15+00:00\",\"dateModified\":\"2025-07-23T23:30:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/\"},\"wordCount\":559,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MCO-PublicationFIN.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/\",\"name\":\"Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MCO-PublicationFIN.jpg\",\"datePublished\":\"2025-07-22T12:10:15+00:00\",\"dateModified\":\"2025-07-23T23:30:25+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MCO-PublicationFIN.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MCO-PublicationFIN.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/22\\\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u72ec\u81ea\u306e\u5e83\u5e2f\u57df\u304b\u3064\u9ad8\u901f\u306a\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u6280\u8853\u306e\u4f5c\u7528\u6a5f\u5e8f\u306e\u8a73\u7d30\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-07-22T12:10:15+00:00","article_modified_time":"2025-07-23T23:30:25+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology","datePublished":"2025-07-22T12:10:15+00:00","dateModified":"2025-07-23T23:30:25+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/"},"wordCount":559,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MCO-PublicationFIN.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/","url":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u72ec\u81ea\u306e\u5e83\u5e2f\u57df\u304b\u3064\u9ad8\u901f\u306a\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u6280\u8853\u306e\u4f5c\u7528\u6a5f\u5e8f\u306e\u8a73\u7d30\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MCO-PublicationFIN.jpg","datePublished":"2025-07-22T12:10:15+00:00","dateModified":"2025-07-23T23:30:25+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MCO-PublicationFIN.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MCO-PublicationFIN.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/22\/nanoscope-therapeutics-publishes-mechanism-of-action-details-for-proprietary-broadband-and-fast-multi-characteristic-opsin-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/9216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=9216"}],"version-history":[{"count":7,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/9216\/revisions"}],"predecessor-version":[{"id":9225,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/9216\/revisions\/9225"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/9217"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=9216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=9216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=9216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}